About this trial
Total knee arthroplasty (TKA) is a frequently performed major orthopedic surgery, where most patients experience severe postoperative pain. Pain-related delays in patient mobilization can lead to thromboembolism, deep vein thrombosis, surgical site infection, and increased risk of hospital-acquired infections due to prolonged hospital stay. Optimal postoperative knee analgesia is crucial not only for patient comfort and satisfaction but also for accelerating mobilization, functional recovery, and discharge from the hospital. To facilitate early ambulation and superior performance, multimodal analgesia and motor-sparing blocks are increasingly utilized
Eligibility criteria
Qualifiers
Patients with written informed consent
Patients over 18 years old undergoing elective total knee arthroplasty surgery
Patients with ASA I-II-III
Patients receiving spinal anesthesia
Disqualifiers
Revision knee arthroplasty and bilateral total knee arthroplasty
Liver or kidney failure
Patients under 18 years old
Patients receiving general anesthesia
Trial design
Treatments tested in this trial
- rescue analgesia
- Adductor Canal Block
- Adding an IPACK Block to the Adductor Canal Block